HIV Drug Discovery and Research

The development of drugs for HIV infection began soon after the virus was discovered 25 years ago. Since then, progress has been substantial, but numerous uncertainties persist about the best way to manage this disease. Here we review the current treatment options, consider novel mechanisms that can be exploited for existing drug targets, and explore the potential of novel targets. With a view to the next quarter century, we consider whether drug resistance can be avoided, which drug classes will be favoured over others, which strategies are most likely to succeed, and the potential impact of pharmacogenomics and individualized therapy.

  • Classes of drugs and mechanism
  • Immunology and strategies towards HIV and retroviral infections
  • HIV/AIDS and STDs/STIs: Vaccines research and development
  • Nucleoside analogues and molecular mechanisms
  • HIV: Current pharmaceutical design

Related Conference of HIV Drug Discovery and Research

September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE

9th European Immunology Conference

June 14-16, 2018 Rome, Italy

HIV Drug Discovery and Research Conference Speakers

Recommended Sessions

Related Journals

Are you interested in